Compound Detail
CHEMBL5083458
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5083458 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HCFZOYBEELAHRR-QPPBQGQZSA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
13
Publications
0
Known Names
Molecular Properties
421.6
MW (Da)
2.64
ALogP
6
HBA
2
HBD
62.3
PSA (Ų)
0.61
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 7.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.8 | 6.8 | 160.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 5.06 | 5.06 | 8800.0 | 1 |
| Kappa-type opioid receptor CHEMBL237 | IC50 | 5.0 | 5.0 | 10100.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| Mu-type opioid receptor CHEMBL233 | IC50 | 4.68 | 4.68 | 21000.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 4.62 | 4.62 | 24000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus 1 | IC50 | = | 20.0 | nM | 7.7 | Antiviral activity against HIV-1 NL4-3(X4) pseudovirus infected in human TZM-bl ... | 35179893 |
| Unchecked | IC50 | = | 160.0 | nM | 6.8 | Antagonist activity at human CXCR4 receptor expressed in CCRF-CEM cells assessed... | 35179893 |
| Alpha-2C adrenergic receptor | IC50 | = | 8800.0 | nM | 5.06 | Inhibition of alpha 2C adrenergic receptor (unknown origin) | 35179893 |
| Kappa-type opioid receptor | IC50 | = | 10100.0 | nM | 5.0 | Inhibition of kappa opioid receptor (unknown origin) | 35179893 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 11000.0 | nM | 4.96 | Inhibition of human ERG by [3H]]Astemizole binding assay | 35179893 |
| Mu-type opioid receptor | IC50 | = | 21000.0 | nM | 4.68 | Inhibition of mu opioid receptor (unknown origin) | 35179893 |
| Alpha-2A adrenergic receptor | IC50 | = | 24000.0 | nM | 4.62 | Inhibition of alpha 2A adrenergic receptor (unknown origin) | 35179893 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35179893 | 10.1021/acs.jmedchem.1c01564 | ADMET | 5 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Unchecked | 2 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Human immunodeficiency virus 1 | 2 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Cytochrome P450 2D6 | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | TZM | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Alpha-2A adrenergic receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Alpha-2C adrenergic receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Mu-type opioid receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Kappa-type opioid receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | D(2) dopamine receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Muscarinic acetylcholine receptor M2 | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Neuronal acetylcholine receptor subunit alpha-7 | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine